Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits

Journal of Alzheimer's Disease

Volumn 4, Issue 1, 2002, Pages 1-9

  Zatta, Paolo ^a   Zambenedetti, Pamela ^a   Stella, Maria Pia ^a   Licastro, Federico ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Astrocyte activation; A metabolism; Cholesterol fed rabbit; Metallothionein; Microgliosis

Indexed keywords

AMYLOID BETA PROTEIN; METALLOTHIONEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL ACTIVATION; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CONTROLLED STUDY; GLIOSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MULTIINFARCT DEMENTIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RABBIT; RISK FACTOR;

EID: 0036128465     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4101     Document Type: Article

References (58)

1. Partial transfection of liver with synthetic cholesterol 7-alpha hydroxylase transgene is sufficient to stimulate the reduction of cholesterol in the plasma of hypercholesterolemic mice
2. Lipid binding to amyloid β-peptide aggregates: Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids
3. Cholesterol modulates α-secretase cleavage of amyloid precursor protein
4. Are thrombocyte membranes altered in Alzheimer's disease? A morphometric and biochemical study
5. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alphaphenylnitrone
6. Abnormal platelets membrane composition in Alzheimer's-type dementia
7. The underlying molecular mechanism of apolipoprotein E polymorphism: Relationship with lipid disorders, cardiovascular disease and Alzheimer's disease
8. Use of statins in CNS disorders
9. Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: Prevalence, plasma cholesterol levels and cerebrovascular changes
10. Endotoxin induction of murine metallothionein gene expression
11. Overview of cholesterol and lipoprotein metabolism in the brain, liver and extrahepatic organs
12. Simvastatin strongly reduces levels of Alzheimer's disease amyloid β peptide Aβ42 and Aβ40 in vitro and in vivo
13. Endotoxin, TNF, and IL-1 decrease cholesterol 7-alfa-hydroxylase mRNA levels and activity
14. Inhibittion pf HMG-CoA reductase activity by hypercholesterolemia reduces leukocyte recruitment and MCP-1 production
15. Cholesterol decreases secretion of the secreted for of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway
16. Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to beta-amyloid neurotoxicity
17. Roles of the metallothionein farmly of proteins in the central nervous system
18. Modulation of secreted amyloid β precursor protein and amyloid/5 amyloid β-peptide in brain by cholesterol
19. Induction of metallothionein by stress and its molecular mechanism
20. A critical review of brain cholesterol metabolism
21. Plasma lipids and cholesterol esterification in Alzheimer's disease
22. Alzheimer's peptides Abeta 1-40 and A beta 1-28 inhibit the plasma cholesterol esterification rate
23. High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia
24. Ibuprofen suppresses plaque pathology and inflammation in a mose model for Alzheimer's disease
25. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis
26. A cadmium protein from equine kidney cortex
27. X-ray diffraction analysis of brain lipid membrane structure in Alzheimer's disease and beta-amyloid peptide interactions
28. Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol
29. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population
30. Zinc-bound metallothionein (I+II) as potential biological marker of ageing
31. Indomethacin reverses the microglial response to amyloid betaprotein
32. Apolipoprotein E in animal model of CNS injury and Alzheimer's disease
33. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content
34. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
35. Ceramide, triglyceride, and sterol ester in normal human whole brain at different ages
36. Chromosome location and human metallothionein genes: Implications in Menkes' disease
37. Regulation, linkage, and sequence of mouse metallothionein I and II genes
38. Cholesterol depletion inhibits the generation of amyloid β in hippocampal neurons
39. Phagocytosis of myelin by microglia in vitro
40. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type
41. Induction of Alzheimer-like amyloid β immunoreactivity in the brains of rabbits with dietary cholesterol
42. Increased incidence of neurofibrillary tangles (NFT) in non-dmented individuals with hypertension
43. Intraceuronal β-amiloyd immunoreactivity in the CNS
44. Coronary artery disease, hypertension, apoE, and cholesterol: A link to Alzheimer's disease?
45. The brain's immune system
46. Activation of microglia in the brain of humans with heart disease and hypercholesterolemic rabbits
47. Apolipoprotein E: High affinity binding to beta-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer's
48. Apolipoprotein E and Alzheimer's disease
49. Localization of metallothionein in aged human brain
50. Membrane lipids, selectively diminished in Alzheimer's brain, suggest synapse loss as a primary event in early-onset form (type II) and demyelination in late-onset form (type II)
51. Regional variation in cholesterol synthesis and low density lipoprotein transport in the brain of fetus, newborn and adult animal
52. Decreased myelin lipids in Alzheimer's disease and vascular dementia
53. Human apolipoprotein E: The Alzheimer's disease connection
54. Non-neuronal cells involved in amyloid β deposition in Alzheimer's disease
55. 2+-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes
56. Statin-Alzheimer disease association not yet prove
57. A comparative study of modified Bielschowsky, Bodian and thioflavin S stain on Alzheimer's neurofibrillary tangles
58. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease